Novo Nordisk Balance Sheet Health

Financial Health criteria checks 4/6

Novo Nordisk has a total shareholder equity of DKK106.6B and total debt of DKK21.3B, which brings its debt-to-equity ratio to 20%. Its total assets and total liabilities are DKK314.5B and DKK207.9B respectively. Novo Nordisk's EBIT is DKK104.0B making its interest coverage ratio -197.3. It has cash and short-term investments of DKK30.2B.

Key information

20.0%

Debt to equity ratio

kr.21.28b

Debt

Interest coverage ratio-197.3x
Cashkr.30.23b
Equitykr.106.56b
Total liabilitieskr.207.93b
Total assetskr.314.49b

Recent financial health updates

Recent updates

Does Novo Nordisk (CPH:NOVO B) Have A Healthy Balance Sheet?

Apr 14
Does Novo Nordisk (CPH:NOVO B) Have A Healthy Balance Sheet?

Do Novo Nordisk's (CPH:NOVO B) Earnings Warrant Your Attention?

Mar 18
Do Novo Nordisk's (CPH:NOVO B) Earnings Warrant Your Attention?

Novo Nordisk A/S' (CPH:NOVO B) Price In Tune With Earnings

Dec 30
Novo Nordisk A/S' (CPH:NOVO B) Price In Tune With Earnings

Novo Nordisk (CPH:NOVO B) Seems To Use Debt Rather Sparingly

Dec 12
Novo Nordisk (CPH:NOVO B) Seems To Use Debt Rather Sparingly

Estimating The Intrinsic Value Of Novo Nordisk A/S (CPH:NOVO B)

Nov 24
Estimating The Intrinsic Value Of Novo Nordisk A/S (CPH:NOVO B)

Calculating The Intrinsic Value Of Novo Nordisk A/S (CPH:NOVO B)

Aug 20
Calculating The Intrinsic Value Of Novo Nordisk A/S (CPH:NOVO B)

These 4 Measures Indicate That Novo Nordisk (CPH:NOVO B) Is Using Debt Safely

Aug 02
These 4 Measures Indicate That Novo Nordisk (CPH:NOVO B) Is Using Debt Safely

Estimating The Fair Value Of Novo Nordisk A/S (CPH:NOVO B)

May 22
Estimating The Fair Value Of Novo Nordisk A/S (CPH:NOVO B)

These 4 Measures Indicate That Novo Nordisk (CPH:NOVO B) Is Using Debt Safely

May 04
These 4 Measures Indicate That Novo Nordisk (CPH:NOVO B) Is Using Debt Safely

Novo Nordisk (CPH:NOVO B) Will Pay A Larger Dividend Than Last Year At DKK8.15

Feb 04
Novo Nordisk (CPH:NOVO B) Will Pay A Larger Dividend Than Last Year At DKK8.15

Novo Nordisk (CPH:NOVO B) Has A Rock Solid Balance Sheet

Feb 02
Novo Nordisk (CPH:NOVO B) Has A Rock Solid Balance Sheet

Financial Position Analysis

Short Term Liabilities: NOVO B's short term assets (DKK139.6B) do not cover its short term liabilities (DKK169.7B).

Long Term Liabilities: NOVO B's short term assets (DKK139.6B) exceed its long term liabilities (DKK38.3B).


Debt to Equity History and Analysis

Debt Level: NOVO B has more cash than its total debt.

Reducing Debt: NOVO B's debt to equity ratio has increased from 1% to 20% over the past 5 years.

Debt Coverage: NOVO B's debt is well covered by operating cash flow (511.8%).

Interest Coverage: NOVO B earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.